Business Description
Global Medical REIT Inc
NAICS : 525920
SIC : 6798
ISIN : US37954A2042
Description
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 1.06 | |||||
| Debt-to-EBITDA | 5.54 | |||||
| Interest Coverage | 1.23 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.11 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.1 | |||||
| 3-Year EBITDA Growth Rate | 14.1 | |||||
| 3-Year Book Growth Rate | 1.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | -1.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30 | |||||
| 9-Day RSI | 33.24 | |||||
| 14-Day RSI | 35.28 | |||||
| 6-1 Month Momentum % | -3.64 | |||||
| 12-1 Month Momentum % | -8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 | |||||
| Days Sales Outstanding | 19.22 | |||||
| Days Payable | 176.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 10.41 | |||||
| Dividend Payout Ratio | 15.85 | |||||
| 3-Year Dividend Growth Rate | 1.6 | |||||
| Forward Dividend Yield % | 10.41 | |||||
| 5-Year Yield-on-Cost % | 11.05 | |||||
| 3-Year Average Share Buyback Ratio | -9.9 | |||||
| Shareholder Yield % | 13.87 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.07 | |||||
| Operating Margin % | 26.87 | |||||
| Net Margin % | 14.63 | |||||
| FCF Margin % | 41.43 | |||||
| ROE % | 3.37 | |||||
| ROA % | 1.55 | |||||
| ROIC % | 1.99 | |||||
| ROC (Joel Greenblatt) % | 684.14 | |||||
| ROCE % | 7.53 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-FFO | 9.12 | |||||
| PE Ratio | 35.04 | |||||
| Forward PE Ratio | 325.8 | |||||
| PE Ratio without NRI | 152.08 | |||||
| PS Ratio | 3.77 | |||||
| PB Ratio | 1.04 | |||||
| Price-to-Tangible-Book | 1.21 | |||||
| Price-to-Free-Cash-Flow | 9.09 | |||||
| Price-to-Operating-Cash-Flow | 7.79 | |||||
| EV-to-EBIT | 23.11 | |||||
| EV-to-EBITDA | 10.89 | |||||
| EV-to-Forward-EBITDA | 15.3 | |||||
| EV-to-Revenue | 8.63 | |||||
| EV-to-Forward-Revenue | 9.87 | |||||
| EV-to-FCF | 20.82 | |||||
| Price-to-Graham-Number | 2.86 | |||||
| Earnings Yield (Greenblatt) % | 4.33 | |||||
| FCF Yield % | 11.05 | |||||
| Forward Rate of Return (Yacktman) % | -37.61 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers